Recursion Pharmaceuticals (RXRX.MX) Q2 2026 Earnings

May 6Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-10.15
-8.03
-5.91
-3.8

Details

Expected EPS
-4.571356
Actual EPS
-3.795088
Surprise EPS
0.78
Surprise Percent
+16.98%

Description

⁨Recursion Pharmaceuticals⁩ (⁦RXRX.MX⁩) has reported earnings of ⁦-3.795088⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts